Chemfab Alkalis Reports Decline in Performance for Q3 2024, Investors Advised to Exercise Caution

Chemfab Alkalis, a smallcap chemical company, recently declared its financial results for the quarter ending September 2024. The company's stock has been given a 'Sell' call by MarketsMOJO, indicating a negative outlook for investors.

According to the financial report, Chemfab Alkalis has seen a decline in its performance with a score of -15, compared to -20 in the previous quarter. This is a cause for concern for the company and its shareholders.

One of the major factors contributing to this decline is the Profit After Tax (PAT) which has fallen by 112% to -0.53 crore, compared to an average PAT of 4.43 crore in the previous four quarters. This indicates a negative trend in the company's near-term profitability.

The Earnings per Share (EPS) for the quarter is also at its lowest in the last five quarters, at -0.37. This shows a decline in the company's ability to generate earnings for its shareholders.

Moreover, Chemfab Alkalis' cash and cash equivalents have also decreased to 2.79 crore in the last six half-yearly periods, indicating a deterioration in short-term liquidity.

Another concerning factor is the Debtors Turnover Ratio, which is at its lowest in the last five half-yearly periods at 11.59 times. This suggests that the company's pace of settling its debtors has slowed down.

Overall, the financial results for the quarter ending September 2024 show a negative performance for Chemfab Alkalis. Investors are advised to carefully consider these factors before making any investment decisions.